Sign up to save your podcasts
Or
Share Everything You Need to Know About the CAPTURE Clinical Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Everything You Need to Know About the CAPTURE Clinical Trial
The CAPTURE clinical trial aims to improve survival rates for women and men with ER+ HER2- breast cancer. This study will investigate the effectiveness of treatment with targeted cancer therapy (alpelisib) and chemotherapy (fulvestrant), compared to a chemotherapy (capecitabine) alone in men and women with ER+ HER2- breast cancer with a PIKC3A mutation.We spoke with the CAPTURE study chair, Professor Sarah-Jane Dawson, about this important clinical trial.
View all episodes
By Breast Cancer TrialsThe CAPTURE clinical trial aims to improve survival rates for women and men with ER+ HER2- breast cancer. This study will investigate the effectiveness of treatment with targeted cancer therapy (alpelisib) and chemotherapy (fulvestrant), compared to a chemotherapy (capecitabine) alone in men and women with ER+ HER2- breast cancer with a PIKC3A mutation.We spoke with the CAPTURE study chair, Professor Sarah-Jane Dawson, about this important clinical trial.